Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenoreceptor blockade in hypertension.

A R Lorimer, F G Dunn, J V Jones

    The American Journal of Medicine
    |May 31, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Experiences of Māori veterinarians and veterinary nurses in the veterinary sector in Aotearoa New Zealand.

    New Zealand veterinary journal·2026
    Same author

    Client experiences with veterinary professionals: a narrative inquiry study.

    New Zealand veterinary journal·2024
    Same author

    Winning hearts and minds: ECG reporting in the first seizure clinic.

    BMC cardiovascular disorders·2021
    Same author

    Adopting seven-day working in practice: a report by the Royal College of Physicians and Surgeons of Glasgow.

    Scottish medical journal·2014
    Same author

    Limited clinical utility of CT coronary angiography in a district hospital setting.

    QJM : monthly journal of the Association of Physicians·2010
    Same author

    The burden of atrial fibrillation in unselected acute medical admissions.

    Scottish medical journal·2008
    Same journal

    Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

    The American journal of medicine·2026
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric panniculitis.

    The American journal of medicine·2026
    See all related articles

    Beta-blocker therapy effectively treats hypertension across all severities, alone or combined with other drugs. These medications offer consistent blood pressure reduction without causing postural hypotension, though their exact mechanism requires further study.

    Area of Science:

    • Cardiovascular Pharmacology
    • Hypertension Management

    Background:

    • Beta-adrenoreceptor blockade is a well-established therapeutic strategy for hypertension.
    • Multiple beta-blocking agents are available, demonstrating comparable hypotensive efficacy.

    Purpose of the Study:

    • To review the evidence supporting beta-adrenoreceptor blockade in hypertension treatment.
    • To discuss the efficacy, mechanism of action, and safety profile of beta-blockers.

    Main Methods:

    • Review of existing scientific literature and clinical studies on beta-blocker therapy.
    • Analysis of reported hypotensive effects, including postural changes and stress response.

    Main Results:

    • Beta-blockers are effective in mild, moderate, and severe hypertension, used as monotherapy or adjuncts.

    Related Experiment Videos

  • Consistent hypotensive effects observed in both supine and standing positions, mitigating postural hypotension.
  • Potential to manage blood pressure surges during mental or physical stress with a low incidence of serious side effects.

    • Conclusions:

    • Beta-adrenoreceptor blockade is a valuable tool in managing hypertension.
    • The precise mechanism of action remains uncertain, with several hypotheses proposed but unproven.
    • Long-term comparative studies are needed to fully establish the role of beta-blockers in hypertension management.